Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3109408rdf:typepubmed:Citationlld:pubmed
pubmed-article:3109408lifeskim:mentionsumls-concept:C0010798lld:lifeskim
pubmed-article:3109408lifeskim:mentionsumls-concept:C0030015lld:lifeskim
pubmed-article:3109408lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:3109408lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:3109408lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:3109408lifeskim:mentionsumls-concept:C0053201lld:lifeskim
pubmed-article:3109408pubmed:issue1lld:pubmed
pubmed-article:3109408pubmed:dateCreated1987-7-15lld:pubmed
pubmed-article:3109408pubmed:abstractTextThe principal oxidative metabolites formed from benzo(c)phenanthrene (B(c)Ph) by the cytochromes P450 in liver microsomes from control and treated rats are the 3,4- and 5,6-arene oxides. A procedure is described which allows determination of the enantiomer composition and absolute configuration of these arene oxides based on HPLC separation of isomeric thiolate adducts formed with N-acetyl-L-cysteine in base. Incubation of [3H]-B(c)Ph with highly purified cytochrome P450c in a reconstituted monooxygenase system followed by trapping of the metabolically formed arene oxides as above indicated that the 3,4-oxide was predominantly the (+)-(3S,4R)-enantiomer (90%) and that the 5,6-oxide consisted mainly of the (+)-(5S,6R)-enantiomer (76%). The results are discussed in terms of their implications about the catalytic binding site of cytochrome P450c.lld:pubmed
pubmed-article:3109408pubmed:languageenglld:pubmed
pubmed-article:3109408pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:citationSubsetIMlld:pubmed
pubmed-article:3109408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3109408pubmed:statusMEDLINElld:pubmed
pubmed-article:3109408pubmed:monthMaylld:pubmed
pubmed-article:3109408pubmed:issn0006-291Xlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:LevinWWlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:ThakkerD RDRlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:JerinaD MDMlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:ThomasP EPElld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:RyanD EDElld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:BoydD RDRlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:BalaniS KSKlld:pubmed
pubmed-article:3109408pubmed:authorpubmed-author:SayerJ MJMlld:pubmed
pubmed-article:3109408pubmed:issnTypePrintlld:pubmed
pubmed-article:3109408pubmed:day29lld:pubmed
pubmed-article:3109408pubmed:volume145lld:pubmed
pubmed-article:3109408pubmed:ownerNLMlld:pubmed
pubmed-article:3109408pubmed:authorsCompleteYlld:pubmed
pubmed-article:3109408pubmed:pagination160-7lld:pubmed
pubmed-article:3109408pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:meshHeadingpubmed-meshheading:3109408-...lld:pubmed
pubmed-article:3109408pubmed:year1987lld:pubmed
pubmed-article:3109408pubmed:articleTitleStereoselective formation of benzo(c)phenanthrene (+)-(3S,4R) and (+)-(5S,6R)-oxides by cytochrome P450c in a highly purified and reconstituted system.lld:pubmed
pubmed-article:3109408pubmed:publicationTypeJournal Articlelld:pubmed